Structure and stability of warfarin-sodium inclusion complexes formed with permethylated monoamino-β-cyclodextrin

Journal of Pharmaceutical and Biomedical Analysis

Volumn 72, Issue , 2013, Pages 292-298

  Tárkányi, Gábor ^a   Németh, Krisztina ^a   Mizsei, Réka ^a   Todoubleacuteke, Orsolya ^a   Visy, Júlia ^a   Simonyi, Miklós ^a   Jicsinszky, László ^b   Szemán, Julianna ^b   Szente, Lajos ^b  

^a INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^b CycloLab Cyclodextrin Research & Development Laboratory Ltd   (Hungary)

Author keywords

Cationic selector; Complex stability constant; Enantiomer migration order reversal; NOE distance restraints; Primary side inclusion

Indexed keywords

BETA CYCLODEXTRIN DERIVATIVE; PERMETHYLATED MONOAMINO BETA CYCLODEXTRIN; UNCLASSIFIED DRUG; WARFARIN;

AQUEOUS SOLUTION; ARTICLE; CAPILLARY ELECTROPHORESIS; CHEMICAL STRUCTURE; DIASTEREOISOMER; ENANTIOMER; ENANTIOSELECTIVITY; METHYLATION; MOLECULAR INTERACTION; MOLECULAR MODEL; MOLECULAR STABILITY; NUCLEAR OVERHAUSER EFFECT; PH; PRIORITY JOURNAL; PROTEIN STABILITY; PROTON NUCLEAR MAGNETIC RESONANCE;

BETA-CYCLODEXTRINS; CARBOHYDRATES; DRUG STABILITY; HYDROGEN-ION CONCENTRATION; MAGNETIC RESONANCE SPECTROSCOPY; STRUCTURE-ACTIVITY RELATIONSHIP; WARFARIN;

EID: 84869088091     PISSN: 07317085     EISSN: 1873264X     Source Type: Journal    
DOI: 10.1016/j.jpba.2012.09.003     Document Type: Article

References (37)

1. Limdi N.A., Veenstra D.L. Warfarin pharmacogenetics. Pharmacotherapy 2008, 28:1084-1097.
2. White R.H., Zhou H., Romano P., Mungall D. Changes in plasma warfarin levels and variations in steady-state prothrombin times. Clin. Pharmacol. Ther. 1995, 58:588-593.
3. Armstrong D.W., Ward T.J., Armstrong R.D., Beesley T.E. Separation of drug stereoisomers by the formation of beta-cyclodextrin inclusion complexes. Science 1986, 232:1132-1135.
4. Gareil P., Gramond J.P., Guyon F. Separation and determination of warfarin enantiomers in human plasma samples by capillary zone electrophoresis using a methylated β-cyclodextrin-containing electrolyte. J. Chromatogr. 1993, 615:317-325.
5. Zhu X.F., Lin B.C., Epperlein U., Koppenhoefer B. Enantiomeric resolution of some nonsteroidal antiinflammatory and anticoagulant drugs using beta-cyclodextrins by capillary electrophoresis. Chirality 1999, 11:56-62.
6. Chankvetadze B., Burjanadze N., Crommen J., Blaschke G. Enantioseparation of warfarin by capillary electrophoresis with UV and LIF detection using single and dual cyclodextrin type chiral selectors. Chromatographia 2001, 53:S296-S301.
7. Chankvetadze B., Blaschke G. Enantioseparations in capillary electromigration techniques: recent developments and future trends. J. Chromatogr. A 2001, 906:309-363.
8. Fanali S., Camera E. Use of methylamino-beta-cyclodextrin in capillary electrophoresis. Resolution of acidic and basic enantiomers. Chromatographia 1996, 43:247-253.
9. Fanali S. Enantiomeric separations by electrophoretic techniques. J. Chromatogr. A 1997, 792:227-267.
10. Varga G., Tárkányi G., Németh K., Iványi R., Jicsinszky L., Todoubleacuteke O., Visy J., Szente L., Szemán J., Simonyi M. Chiral separation by a monofunctionalized cyclodextrin derivative: From selector to permethyl-beta-cyclodextrin bonded stationary phase. J. Pharm. Biomed. Anal. 2010, 51:84-89.
11. Szejtli J. Introduction and general overview of cyclodextrin chemistry. Chem. Rev. 1998, 98:1743-1753.
12. Iványi R., Jicsinszky L., Juvancz Z. Permethyl monoamino β-cyclodextrin new chiral selective agents for capillary electrophoresis. Chromatographia 2001, 53:166-172.
13. Iványi R., Jicsinszky L., Juvancz Z. Chiral separation of pyrethroic acids with single isomer permethyl monoamino β-cyclodextrin selector. Electrophoresis 2001, 22:3232-3236.
14. Porter W.R. Warfarin: history, tautomerism and activity. J. Comput. Aided Mol. Des. 2010, 24:553-573.
15. Henschel H., Karlsson B.C.G., Rosengren A.M., Nicholls I.A. The mechanistic basis for warfarin's structural diversity and implications for its bioavailability. J. Mol. Struct. Theochem. 2010, 958:7-9.
16. Nicholls I.A., Karlsson B.C.G., Rosengren A.M., Henschel H. Warfarin: an environment-dependent switchable molecular probe. J. Mol. Recognit. 2010, 23:604-608.
17. Valente E.J., Lingafelter E.C., Porter W.R., Trager W.F. Structure of warfarin in solution. J. Med. Chem. 1977, 20:1489-1493.
18. Valente E.J., Porter W.R., Trager W.F. The conformation of selected 3-substituted 4-hydroxycoumarins in solution by NMR: warfarin and phenprocoumon. J. Med. Chem. 1978, 21:231-234.
19. He M., Korzekwa K.R., Jones J.P., Rettie A.E., Trager W.F. Structural forms of phenprocoumon and warfarin that are metabolized at the active site of CYP2C9. Arch. Biochem. Biophys. 1999, 372:16-28.
20. C.H. Schroeder, L.K. Paul, Warfarin sodium, US patent 3,077,481 (1963).
21. N. Weiner, R. Park, M. Johnson, C.H. Schroeder, Preparation of crystalline warfarin sodium-isopropyl alcohol complex, US patent 3,246,013 (1966).
22. Sheth A.R., Young V.G., Grant D.J.W. Warfarin sodium 2-propanol solvate. Acta Crystallogr. 2002, E58:m197-m199.
23. West B.D., Preis S., Schroeder C.H. Studies on the 4-hydroxycoumarins. XVII. The resolution and absolute configuration of warfarin. J. Am. Chem. Soc. 1961, 83:2676-2679.
24. Jicsinszky L., Iványi R. Catalytic transfer hydrogenation of sugar derivatives. Carbohydr. Polym. 2001, 45:139-145.
25. Tanaka Y., Terabe S. Estimation of binding constants by capillary electrophoresis. J. Chromatogr. B 2002, 768:81-92.
26. Scriba G.K.E. Fundamental aspects of chiral electromigration techniques and application in pharmaceutical and biomedical analysis. J. Pharm. Biomed. Anal. 2011, 55:688-701.
27. Brown D.E. Improved baseline recognition and modeling of FT NMR spectra. J. Magn. Reson. Ser. A 1995, 114:268-270.
28. Brooks B.R., Bruccoleri R.E., Olafson B.D., States D.J., Swaminathan S., Karplus M. CHARMM - a program for macromolecular energy, minimization, and dynamics calculations. J. Comput. Chem. 1983, 4:187-217.
29. Eliseev A.V., Schneider H.J. Molecular recognition of nucleotides, nucleosides, and sugars by aminocyclodextrins. J. Am. Chem. Soc. 1994, 116:6081-6088.
30. Tárkányi G. Quantitative approach for the screening of cyclodextrins by nuclear magnetic resonance spectroscopy in support of chiral separations in liquid chromatography and capillary electrophoresis - enantioseparation of norgestrel with alpha-, beta- and gamma-cyclodextrins. J. Chromatogr. A 2002, 961:257-276.
31. Ringo M.C., Evans C.E. Liquid chromatography as a measurement tool: chromatographic assessment of chiral recognition. Anal. Chem. 1998, 70:315A-321A.
32. Fielding L. Determination of association constants (Ka) from solution NMR data. Tetrahedron 2000, 56:6151-6170.
33. Diaz E.T., Jankowski C.K., Hocquelet C., F.del Rio P., Barrios H. The unambiguous assignment of NMR spectra of per-O-methylated 6-mono and 6,6-diamino-β-cyclodextrins. Can. J. Chem. 2008, 86:726-736.
34. 2O solution. Chem. Pharm. Bull. 2009, 57:653-656.
35. West L.C., Wyness O., May B.L., Clements P., Lincoln S.F., Easton C.J. Diazacoronand linked β-cyclodextrin dimer complexes of brilliant yellow tetraanion and their sodium(I) analogues. Org. Biomol. Chem. 2003, 1:887-894.
36. Lock J.S., May B.L., Clements P., Lincoln S.F., Easton C.J. Cyclodextrin complexation of a stilbene and the self-assembly of a simple molecular device. Org. Biomol. Chem. 2004, 2:337-344.
37. Nishio M. The CH/π hydrogen bond in chemistry. Conformation, supramolecules, optical resolution and interactions involving carbohydrates. Phys. Chem. Chem. Phys. 2011, 13:13873-13900.